The point-of-care rapid diagnostic test enables simultaneous diagnosis of both syphilis and HIV in under 20 minutes from a single finger-prick sample.
Unitaid, the Clinton Health Access Initiative, and Laurus Labs announce agreement to accelerate development of best-in-class second- and third-line HIV medication for children.
The report provides market intelligence on hepatitis C diagnostics and drugs in low- and middle-income countries and covers preliminary insights into the hepatitis B market.
CHAI is pleased to share an announcement from MedAccess of measures to increase access to a patient-friendly preventative therapy for TB.
We are deeply saddened to share the news of the passing of our Board Chair, Dr. Tachi Yamada.
Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) announce pricing agreement with pharmaceutical company Hetero Labs LTD to make available generic version of best-in-class second-line therapy for people living with HIV.
A full list of sessions that CHAI is participating in at the Internationl AIDS Society conference.
Through this MOU, GARDP, CHAI and Shionogi will use their collective expertise to increase access to cefiderocol in low- and middle-income countries.
CHAI today announced that Joy Phumaphi, Botswana’s former Minister of Health, and Ann Veneman, the former Executive Director of UNICEF, have been named interim co-CEOs.
Agreement brokered by Unitaid and CHAI under the COVID-19 Oxygen Emergency Taskforce sees two of the world’s largest medical oxygen suppliers each collaborate with these ACT-Accelerator partners on increased access to oxygen.
